Literature DB >> 32741842

Hallucinations and Development of Dementia in Parkinson's Disease.

Wojciech Gryc1,2, Kathryn A Roberts1,2, Cyrus P Zabetian1,2, Daniel Weintraub3,4,5, John Q Trojanowski6,7, Joseph F Quinn8,9, Amie L Hiller8,9, Kathryn A Chung8,9, Kathleen L Poston10, Laurice Yang10, Shu-Ching Hu1,2, Karen L Edwards11, Thomas J Montine12, Brenna A Cholerton12.   

Abstract

Neuropsychiatric symptoms are common in Parkinson's disease (PD). We investigated the relationship between neuropsychiatric symptoms and current and future diagnosis of PD dementia (PDD). Individuals with PD who had a study partner were enrolled (n = 696). Study partners were administered the Neuropsychiatric Inventory or Neuropsychiatric Inventory Questionnaire at baseline. Participants were assigned a cognitive diagnosis at baseline and follow up visits. Hallucinations were significantly associated with a diagnosis of PDD cross-sectionally (p < 0.001) and with shortened time to dementia longitudinally among initially nondemented participants (n = 444; p = 0.005). Screening for hallucinations may be useful for assessing risk of dementia in participants with PD.

Entities:  

Keywords:  Behavioral symptoms; Parkinson’s zzm321990disease; cognition; dementia; hallucinations

Year:  2020        PMID: 32741842      PMCID: PMC7609584          DOI: 10.3233/JPD-202116

Source DB:  PubMed          Journal:  J Parkinsons Dis        ISSN: 1877-7171            Impact factor:   5.568


  29 in total

1.  The rate of cognitive decline in Parkinson disease.

Authors:  Dag Aarsland; Kjeld Andersen; Jan Petter Larsen; Robert Perry; Tore Wentzel-Larsen; Anette Lolk; Per Kragh-Sørensen
Journal:  Arch Neurol       Date:  2004-12

2.  Predictors of dementia in Parkinson's disease; findings from a 5-year prospective study using the SCOPA-COG.

Authors:  Kangdi Zhu; Jacobus J van Hilten; Johan Marinus
Journal:  Parkinsonism Relat Disord       Date:  2014-06-26       Impact factor: 4.891

Review 3.  A systematic review of prevalence studies of dementia in Parkinson's disease.

Authors:  Dag Aarsland; Julia Zaccai; Carol Brayne
Journal:  Mov Disord       Date:  2005-10       Impact factor: 10.338

4.  Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory.

Authors:  D I Kaufer; J L Cummings; P Ketchel; V Smith; A MacMillan; T Shelley; O L Lopez; S T DeKosky
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2000       Impact factor: 2.198

5.  Cognitive changes in Parkinson's disease patients with visual hallucinations.

Authors:  Blanca Ramirez-Ruiz; Carme Junque; Maria-Jose Marti; Francesc Valldeoriola; Eduardo Tolosa
Journal:  Dement Geriatr Cogn Disord       Date:  2007-03-14       Impact factor: 2.959

Review 6.  Dementia associated with Parkinson's disease.

Authors:  Murat Emre
Journal:  Lancet Neurol       Date:  2003-04       Impact factor: 44.182

7.  A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations.

Authors:  Gabriella Santangelo; Luigi Trojano; Carmine Vitale; Marta Ianniciello; Marianna Amboni; Dario Grossi; Paolo Barone
Journal:  Mov Disord       Date:  2007-12       Impact factor: 10.338

8.  APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease.

Authors:  Ignacio F Mata; James B Leverenz; Daniel Weintraub; John Q Trojanowski; Howard I Hurtig; Vivianna M Van Deerlin; Beate Ritz; Rebecca Rausch; Shannon L Rhodes; Stewart A Factor; Cathy Wood-Siverio; Joseph F Quinn; Kathryn A Chung; Amie L Peterson; Alberto J Espay; Fredy J Revilla; Johnna Devoto; Shu-Ching Hu; Brenna A Cholerton; Jia Y Wan; Thomas J Montine; Karen L Edwards; Cyrus P Zabetian
Journal:  JAMA Neurol       Date:  2014-11       Impact factor: 18.302

Review 9.  Clinical diagnostic criteria for dementia associated with Parkinson's disease.

Authors:  Murat Emre; Dag Aarsland; Richard Brown; David J Burn; Charles Duyckaerts; Yoshikino Mizuno; Gerald Anthony Broe; Jeffrey Cummings; Dennis W Dickson; Serge Gauthier; Jennifer Goldman; Christopher Goetz; Amos Korczyn; Andrew Lees; Richard Levy; Irene Litvan; Ian McKeith; Warren Olanow; Werner Poewe; Niall Quinn; Christina Sampaio; Eduardo Tolosa; Bruno Dubois
Journal:  Mov Disord       Date:  2007-09-15       Impact factor: 10.338

View more
  1 in total

1.  High risk of developing dementia in Parkinson's disease: a Swedish registry-based study.

Authors:  Daniel Oudin Åström; Jacob Simonsen; Lars Lau Raket; Simona Sgarbi; Johan Hellsten; Peter Hagell; Jenny M Norlin; Klas Kellerborg; Pablo Martinez-Martin; Per Odin
Journal:  Sci Rep       Date:  2022-10-06       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.